Publications by authors named "Kent Summers"

Claim this Profile
D
Descriptive study of the real-world, long-term cost estimates and duration of use for hormonal and nonhormonal intrauterine devices using US commercial insurance claims.
Brian T Nguyen, Katrina Heyrana, Robert Ohsfeldt, Adam Johnston, Kent Summers

J Manag Care Spec Pharm· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The prevalence of opioid-related major potential drug-drug interactions and their impact on health care costs in chronic pain patients.
Joseph V Pergolizzi, Larry Ma, David R Foster, Brian R Overholser, Kevin M Sowinski, Kent H Summers

J Manag Care Spec Pharm· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a questionnaire to assess the impact of chronic low back pain for use in regulated clinical trials.
Jonathan Stokes, Christopher J Evans, Farrah Pompilus, Alan L Shields, Kent H Summers

Patient· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic implications of potential drug-drug interactions in chronic pain patients.
Robert Taylor, Joseph V Pergolizzi, R Amy Puenpatom, Kent H Summers

Expert Rev Pharmacoecon Outcomes Res· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estimated economic benefits from low-frequency administration of atypical antipsychotics in treatment of schizophrenia: a decision model.
Nicolas M Furiak, James C Gahn, Robert W Klein, Stephen B Camper, Kent H Summers

Ann Gen Psychiatry· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a men's Preference for Testosterone Replacement Therapy (P-TRT) instrument.
Sheryl L Szeinbach, Enrique Seoane-Vazquez, Kent H Summers

Patient Prefer Adherence· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Direct and indirect costs of patients treated with extended-release oxymorphone HCl or controlled-release oxycodone HCl.
Noam Y Kirson, Alan G White, Howard G Birnbaum, Matt Schiller, Tracy Waldman, Kent H Summers

J Med Econ· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic impact of potential CYP450 pharmacokinetic drug-drug interactions among chronic low back pain patients taking opioids.
Joseph V Pergolizzi, Sumedha A Labhsetwar, R Amy Puenpatom, Rami Ben-Joseph, Robert Ohsfeldt, Kent H Summers

Pain Pract· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic impact of potential drug-drug interactions among osteoarthritis patients taking opioids.
Joseph V Pergolizzi, Sumedha A Labhsetwar, R Amy Puenpatom, Rami Ben-Joseph, Robert Ohsfeldt, Kent H Summers

Pain Pract· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Daily average consumption of 2 long-acting opioids: an interrupted time series analysis.
R Amy Puenpatom, Sheryl L Szeinbach, Larry Ma, Rami H Ben-Joseph, Kent H Summers

Am Health Drug Benefits· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exposure to potential CYP450 pharmacokinetic drug-drug interactions among osteoarthritis patients: incremental risk of multiple prescriptions.
Joseph V Pergolizzi, Sumedha A Labhsetwar, R Amy Puenpatom, Seongjung Joo, Rami Ben-Joseph, Kent H Summers

Pain Pract· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic impact of potential drug-drug interactions in opioid analgesics.
Kent H Summers, R Amy Puenpatom, Niveda Rajan, Rami Ben-Joseph, Robert Ohsfeldt

J Med Econ· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence of exposure to potential CYP450 pharmacokinetic drug-drug interactions among patients with chronic low back pain taking opioids.
Joseph V Pergolizzi, Sumedha A Labhsetwar, R Amy Puenpatom, Seongjung Joo, Rami H Ben-Joseph, Kent H Summers

Pain Pract· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparing healthcare costs of Medicaid patients with postherpetic neuralgia (PHN) treated with lidocaine patch 5% versus gabapentin or pregabalin.
Noam Y Kirson, Jasmina I Ivanova, Howard G Birnbaum, Robert Wei, Evan Kantor, Kent H Summers

J Med Econ· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%.
Noam Y Kirson, Jasmina I Ivanova, Howard G Birnbaum, Robert Wei, Evan Kantor, Kent H Summers

J Med Econ· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of daily average consumption (DACON) of oxycodone and oxymorphone long-acting oral tablets.
Mark Rubino, Kent H Summers, Amy Puenpatom, Chunmay Fu, Robert L Ohsfeldt

J Manag Care Pharm· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predicting EQ-5D utility scores from the 25-item National Eye Institute Vision Function Questionnaire (NEI-VFQ 25) in patients with age-related macular degeneration.
Nalin Payakachat, Kent H Summers, Andreas M Pleil, Matthew M Murawski, Joseph Thomas

Qual Life Res· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health utility and economic analysis: theoretical and practical issues.
Nalin Payakachat, Matthew M Murawski, Kent H Summers

Expert Rev Pharmacoecon Outcomes Res· August 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges and opportunities in pharmacogenomics and therapeutics.
Michael D Kane, Kent H Summers

J Manag Care Pharm· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmaceutical manufacturer prescription assistance programs: are they worth it?
Judy T Chen, Kent H Summers

J Manag Care Pharm· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Medication therapy management versus drug regimen review.
Kent H Summers

J Manag Care Pharm· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal clinically important differences in Incontinence Quality-of-Life scores in stress urinary incontinence.
Ilker Yalcin, Donald L Patrick, Kent Summers, Kraig Kinchen, Richard C Bump

Urology· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of clinical practice guidelines in the initial pharmacological management of new-onset epilepsy in adults.
Nalin Payakachat, Kent H Summers, John P Barbuto

J Manag Care Pharm· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacist intervention in safe and effective conversion of brand to generic drugs.
Kent H Summers

J Manag Care Pharm· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quality assessment of clinical practice guidelines.
Kent H Summers, Nalin Payakachat

Expert Rev Pharmacoecon Outcomes Res· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis